Toxicity/Toxemia Clinical Trials
- Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
ClinicalTrials.gov Identifier: NCT00017004 - Active, not recruiting
Anemia; Cervical Cancer; Drug Toxicity; Quality of Life; radiation toxicity
- Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003583 - Active, not recruiting
limited stage small cell lung cancer; Drug Toxicity; radiation toxicity
- NRTI-Sparing Pilot Study
ClinicalTrials.gov Identifier: NCT00143689 - Active, not recruiting
HIV; Mitochondrial Toxicity
- Cytokines Polymorphisms and Acetaminophen Toxicity
ClinicalTrials.gov Identifier: NCT00166608 - Recruiting
Drug Toxicity
- Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004176 - Active, not recruiting
limited stage small cell lung cancer; Drug Toxicity; radiation toxicity
- Toxicity Substudy of ESPRIT: TOXIL-2 Substudy
ClinicalTrials.gov Identifier: NCT00147355 - Recruiting
rIL-2-toxicity; interleukin-2 therapy; HIV
- Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
- Treatment Targets for Chronic Hypertension in Pregnancy
ClinicalTrials.gov Identifier: NCT00194974 - Recruiting
Pregnancy Toxemia; Hypertension; Proteinuria
- Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Doxorubicin
ClinicalTrials.gov Identifier: NCT00577798 - Recruiting
Cardiac Toxicity; Chemotherapeutic Agent Toxicity; Lymphoma
- Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00077311 - Active, not recruiting
Anemia; Drug Toxicity; Neutropenia; Non-small cell lung cancer
- Velafermin (CG53135-05) in Preventing Oral Mucositis in Patients Receiving Chemotherapy and/or Total-Body Irradiation Followed By An Autologous Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00124592 - Recruiting
Cancer; Drug Toxicity; oral complications of cancer and cancer therapy; radiation toxicity
- Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
ClinicalTrials.gov Identifier: NCT00563407 - Recruiting
Genetic Markers; Cardiac Toxicity; Breast and Skin Motion
- Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00003144 - Active, not recruiting
Drug Toxicity; unspecified adult solid tumor, protocol specific
- Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00055718 - Active, not recruiting
Drug Toxicity; childhood acute lymphoblastic leukemia
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
ClinicalTrials.gov Identifier: NCT00075868 - Active, not recruiting
Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
- Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00024427 - Active, not recruiting
adenocarcinoma of the pancreas; Drug Toxicity; Pancreatic Cancer
- Chemotherapy and Radiation Therapy With or Without Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00503776 - Recruiting
Chemotherapeutic Agent Toxicity; Dysphagia; Head and Neck Cancer; Mucositis; Radiation Toxicity; Xerostomia
- Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00095927 - Recruiting
Drug Toxicity; Head and Neck Cancer; oral complications of chemotherapy and head and neck radiation; radiation toxicity
- Palifermin in Reducing or Preventing Mucositis in Patients Who Are Receiving Radiation Therapy and Chemotherapy Followed by an Autologous Stem Cell Transplant for Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00126529 - Recruiting
Drug Toxicity; Leukemia; Lymphoma; oral complications of cancer and cancer therapy; plasma cell neoplasm; radiation toxicity
- Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
ClinicalTrials.gov Identifier: NCT00004919 - Active, not recruiting
unspecified childhood solid tumor, protocol specific; Drug Toxicity
- Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
ClinicalTrials.gov Identifier: NCT00002900 - Active, not recruiting
stage I breast cancer; stage II breast cancer; ductal breast carcinoma; cardiac toxicity
- Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
ClinicalTrials.gov Identifier: NCT00093353 - Active, not recruiting
Diarrhea; Drug Toxicity; disseminated neuroblastoma; recurrent neuroblastoma
- Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00004034 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; cardiac toxicity; ...
- Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00090844 - Active, not recruiting
Drug Toxicity; hormonal changes; stage I breast cancer; stage II breast cancer
- Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003313 - Active, not recruiting
oral complications of cancer and cancer therapy; stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; Drug Toxicity; ...
- Chemotherapy Toxicity Reduction Via Urea Cycle Support
ClinicalTrials.gov Identifier: NCT00223730 - Active, not recruiting
Cancer
- Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00024310 - Active, not recruiting
Drug Toxicity; unspecified adult solid tumor, protocol specific
- Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
ClinicalTrials.gov Identifier: NCT00002827 - Active, not recruiting
stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; cardiac toxicity; stage I childhood Hodgkin's disease; ...
- High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003068 - Active, not recruiting
stage IIIB breast cancer; Drug Toxicity; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
ClinicalTrials.gov Identifier: NCT00019864 - Active, not recruiting
Cardiac Toxicity; Sarcoma
- Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00052884 - Active, not recruiting
Drug Toxicity; primary systemic amyloidosis
- Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
ClinicalTrials.gov Identifier: NCT00007007 - Active, not recruiting
cognitive/functional effects; radiation toxicity; brain metastases; Quality of Life
- Isotretinoin With or Without Vitamin E for Prevention of Lung Cancer
ClinicalTrials.gov Identifier: NCT00002586 - Active, not recruiting
Non-small cell lung cancer; Small Cell Lung Cancer; Drug Toxicity
- A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
ClinicalTrials.gov Identifier: NCT00222105 - Active, not recruiting
Multiple Myeloma
- Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00063895 - Active, not recruiting
Drug Toxicity; female reproductive cancer; Head and Neck Cancer; thorax and respiratory cancer
- Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006105 - Active, not recruiting
stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; Drug Toxicity
- Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00028964 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer; Drug Toxicity
- Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
- National Survey of Lead and Allergen Hazards in Housing
ClinicalTrials.gov Identifier: NCT00339573 - Active, not recruiting
Lead Toxicity; Environmental Allergens
- Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
ClinicalTrials.gov Identifier: NCT00025298 - Active, not recruiting
stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer; oral complications of cancer and cancer therapy; ...
- Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003407 - Active, not recruiting
untreated adult acute myeloid leukemia; Drug Toxicity; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
- Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003307 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; radiation toxicity
- Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004264 - Active, not recruiting
Drug Toxicity; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
- Radiation Therapy and Cisplatin With or Without Amifostine in Treating Patients With Stage IIIB or Stage IVA Cancer of the Cervix
ClinicalTrials.gov Identifier: NCT00012012 - Active, not recruiting
radiation toxicity; stage III cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ...
- Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
ClinicalTrials.gov Identifier: NCT00057785 - Active, not recruiting
oral complications of chemotherapy and head/neck radiation; radiation toxicity; stage I squamous cell carcinoma of the nasopharynx; ...
- Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
ClinicalTrials.gov Identifier: NCT00006360 - Active, not recruiting
stage II squamous cell carcinoma of the oropharynx; stage III squamous cell carcinoma of the oropharynx; radiation toxicity
- Voriconazole Blood Levels and Toxicity
ClinicalTrials.gov Identifier: NCT00359541 - Recruiting
Pharmacology
- Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
ClinicalTrials.gov Identifier: NCT00003811 - Active, not recruiting
childhood malignant testicular germ cell tumor; childhood mature and immature teratomas; Drug Toxicity; recurrent childhood malignant germ cell tumor; ...
- Filgrastim Compared With Filgrastim-SD/01 Following Combination Chemotherapy in Treating Patients With Newly Diagnosed Sarcoma
ClinicalTrials.gov Identifier: NCT00020137 - Active, not recruiting
Cardiac Toxicity; Neutropenia; Sarcoma
- FREE Study: Efficacy and Toxicity of Trizivir
ClinicalTrials.gov Identifier: NCT00405925 - Recruiting
HIV Infections
- Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients with HIV/AIDS
ClinicalTrials.gov Identifier: NCT00106795 - Recruiting
- Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00445042 - Recruiting
Carcinoma, Renal Cell
- Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine
ClinicalTrials.gov Identifier: NCT00478686 - Recruiting
Breast Cancer
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
ClinicalTrials.gov Identifier: NCT00564642 - Recruiting
Hepatitis
- Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
ClinicalTrials.gov Identifier: NCT00081029 - Recruiting
Hypopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; radiation toxicity
- Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00131599 - Active, not recruiting
-colon cancer
- Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00122265 - Active, not recruiting
Prostate Cancer
- Amifostine in Protecting the Rectum in Patients Undergoing Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00045253 - Active, not recruiting
Prostate Cancer; Radiation Toxicity
- Gene Expression Profiling and Phototoxicity in Adults and Children Exposed to Ultraviolet Radiation
ClinicalTrials.gov Identifier: NCT00411008 - Recruiting
Drug Toxicity
- PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
ClinicalTrials.gov Identifier: NCT00576706 - Recruiting
Rheumatoid Arthritis; Osteoarthritis; Ankylosing Spondylitis
- Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients
ClinicalTrials.gov Identifier: NCT00578630 - Recruiting
Neoplasms
- Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
ClinicalTrials.gov Identifier: NCT00238173 - Active, not recruiting
Bone Marrow Suppression; Brain and Central Nervous System Tumors; Drug Toxicity; Long-Term Effects Secondary to Cancer Therapy in Children
- RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
- Mannitol Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
ClinicalTrials.gov Identifier: NCT00397501 - Active, not recruiting
Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Drug Toxicity; Psychosocial Effects/Treatment
- A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.
ClinicalTrials.gov Identifier: NCT00000391 - Active, not recruiting
HIV Infections
- STEPP: A Phase 2, Open-Label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-Line Irinotecan Based Chemotherapy
ClinicalTrials.gov Identifier: NCT00332163 - Active, not recruiting
Metastatic Colorectal Cancer; Skin Rash; Skin Toxicities; Colon Cancer; Colorectal Cancer
- A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
ClinicalTrials.gov Identifier: NCT00389311 - Recruiting
HIV Infections
- Oxygen Toxicity in the Resuscitation in Extremely Premature Infants
ClinicalTrials.gov Identifier: NCT00494702 - Recruiting
Asphyxia Neonatorum; Premature Birth
- Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-Small Cell Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00531076 - Recruiting
Toxicity
- Low-Residue Diet in Treating Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis for Uterine, Cervical, or Prostate Cancer
ClinicalTrials.gov Identifier: NCT00258401 - Active, not recruiting
Cervical Cancer; Diarrhea; Prostate Cancer; Quality of Life; Radiation Toxicity; Sarcoma
- Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
ClinicalTrials.gov Identifier: NCT00057811 - Recruiting
acute leukemia; childhood large cell lymphoma; childhood small noncleaved cell lymphoma; Drug Toxicity
- Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00438659 - Active, not recruiting
Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
- A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
ClinicalTrials.gov Identifier: NCT00000652 - Active, not recruiting
HIV Infections
- Long-Term Effects of Therapy in Patients Previously Treated for Childhood Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00020423 - Active, not recruiting
Cardiac Toxicity; Long-Term Effects Secondary to Cancer Therapy in Children; Osteoporosis; Psychosocial Effects/Treatment; Quality of Life; Sarcoma; Sexual Dysfunction and Infertility
- Pegasparaginase or Asparaginase and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00400946 - Recruiting
Drug Toxicity; Leukemia
- A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival
ClinicalTrials.gov Identifier: NCT00461708 - Recruiting
Pancreatic Cancer
- Fertility Preservation by Ovarian and Oocyte Cryopreservation
ClinicalTrials.gov Identifier: NCT00578500 - Recruiting
Female Patients Aged 5-35 Prior to Systemic Chemotherapy; With Significant Risk of Ovarian Toxicity
- Rituximab, Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Sodium Thiosulfate and Cytarabine in Treating Patients With Refractory or Recurrent Primary CNS Lymphoma
ClinicalTrials.gov Identifier: NCT00074165 - Recruiting
Drug Toxicity; Thrombocytopenia; intraocular lymphoma; primary central nervous system lymphoma
- A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).
ClinicalTrials.gov Identifier: NCT00301288 - Recruiting
Non-Hodgkins Lymphoma
- CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
ClinicalTrials.gov Identifier: NCT00514345 - Recruiting
Chemotherapeutic Agent Toxicity; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
- Rituximab, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
ClinicalTrials.gov Identifier: NCT00293475 - Recruiting
Drug Toxicity; Lymphoma
- Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
ClinicalTrials.gov Identifier: NCT00486213 - Recruiting
Chemotherapeutic Agent Toxicity; Dermatologic Complications; Palmar-Plantar Erythrodysesthesia; Unspecified Adult Solid Tumor, Protocol Specific
- Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00220116 - Recruiting
Colorectal Cancer
- Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00031980 - Active, not recruiting
Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia
- Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00352872 - Recruiting
Breast Cancer
- A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00235235 - Recruiting
Breast Cancer
- Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00317798 - Recruiting
Drug Toxicity; Multiple Myeloma and Plasma Cell Neoplasm
- Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
ClinicalTrials.gov Identifier: NCT00537173 - Recruiting
Breast Cancer
- Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles
ClinicalTrials.gov Identifier: NCT00324298 - Recruiting
Drug Toxicity; Testicular Germ Cell Tumor
- Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00519077 - Recruiting
Head and Neck Neoplasms
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00006012 - Completed
Drug Toxicity; radiation toxicity; limited stage small cell lung cancer
- A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).
ClinicalTrials.gov Identifier: NCT00301314 - Recruiting
Hodgkin Lymphoma
- Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
ClinicalTrials.gov Identifier: NCT00436566 - Recruiting
Breast Cancer; Cardiac Toxicity
- Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00019305 - Recruiting
Lymphoma; Radiation Toxicity
- Internet-Based System for Cancer Patients to Self-Report Toxicity
ClinicalTrials.gov Identifier: NCT00578006 - Recruiting
Cervical Cancer; Lung Cancer; Prostate Cancer; Vaginal Cancer; Ovarian Cancer
- Evaluation of Albuminuria HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00524992 - Recruiting
HIV-Associated Focal Segmental Glomerulosclerosis; HIV-Associated Collapsing Glomerulopathy; Proteinuria; Albuminuria; Renal Tubular Toxicity
- Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
ClinicalTrials.gov Identifier: NCT00543049 - Recruiting
Platinum Refractory Epithelial Ovarian Cancer; Primary Cancer of the Peritoneum; Cancer of the Fallopian Tube
- Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
ClinicalTrials.gov Identifier: NCT00499798 - Recruiting
Brain and Central Nervous System Tumors; Chemotherapeutic Agent Toxicity; Sexual Dysfunction and Infertility
- Darbepoetin alfa in Treating Anemia in Patients With Cancer Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00039247 - Active, not recruiting
Anemia; unspecified adult solid tumor, protocol specific
- Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00482846 - Recruiting
Drug Toxicity; Mucositis; Multiple Myeloma and Plasma Cell Neoplasm
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
